the aid library

Key
Resources
Clinical
Guidelines
Women & Child
Health
Pharmacy &
Technologies
Public
Health
Capacity
Building
COUNTRIES
TOOLBOXES
- Conflict
- Zika
- TB
- Cholera
- HIV
- Polio
- Rapid Response
- Refugee
- Disability
- Specific Hazards
- Social Ethics
- Health Financing Toolbox

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America

Login
Register
English

Search database

Suggest new resources

Filter

Text search: QMS

Featured

Recommendations

New Publications

Language

English

French

Document type

No document type

Studies & Reports

Guidelines

Manuals

Strategic & Response Plan

Situation Updates

Countries / Regions

India

Kenya

Nigeria

Ghana

Rwanda

Eswatini/ Swaziland

Uganda

Zimbabwe

Zambia

Tanzania

Bangladesh

Malawi

Asia

Global

Gabon

Burkina Faso

Sierra Leone

Senegal

Cameroon

Nepal

Botswana

East and Southern Africa

Western Pacific Region

Eastern Europe and Central Asia

Western and Central Europe

Eastern Europe

Tajikistan

Georgia

Authors & Publishers

Africa Center for Disease Control and Prevention

World Health Organization WHO

World Health Organisation (WHO)

World Health Organization (WHO)

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh

Ministry of Health, Rwanda

SCMS

World Health Organization

Belkum, A.van, T. T. Bachmann, G. Lüdke, et al.

Brown, T.

CCM Georgia

Center for Disease Control

Centers for Disease Control and Prevention (CDC)

Dacombe R., I. Bates, B. Gopul et al.

Ghana Health Service (GHS)

Global Laboratory Initiative

Global Task Force on Cholera Control (GTFCC)

Government of India, Ministry of Health and Family Welfare, National AIDS Control Organisation (NACO)

Government of the Republic of Zambia

Indian Council of Medical Research India

Kenya Medical Training College (KMTC)

Liverpool School of Tropical Medicine

Ministry of Health and Social Welfare, National AIDS Control Programme, Tanzania

Ministry of Health, Botswana

Ministry of Health, Botswana&#59

Ministry of Health, Kenya

Ministry of Health, Rwanda & Rwanda Biomedical Centre

Ministry of Health, Uganda

Ministry of Health. The Goverment of the Kingdom of Swaziland

NACO

National AIDS

National AIDS Control Organization (NACO), Ministry of Health and Family Welfare (MOHFW), Government of India

PEPFAR

PEPFAR&#59

Pharmacy and Poisons Board, Ministry of Health, Kenya

SAARC Tuberculosis and HIV

The United States President's Emergency Plan for AIDS Relief (PEPFAR)

Thomson, D., Shivanandan, J. & Brown, T.

Thomson, D., Shivanandan, J. &amp

UN Industrial Development Organization

UNITAID

USAID

WHO

World Health Organization (Western Pacific Region)

World Health Organization et al.

World Health Organization WHO, Regional Office for Europe

World Health Organization WHO, Regional Office of Europe

World Health Organization WHO, Western Pacific Region

Publication Years

2020-2026

2010-2019

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Tanzania

Africa Center for Disease Control and Prevention (2023) CC

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr ... ess the emergency. MAAP reviewed 819,584 AMR records from 2016-2019, from 205 laboratories across Burkina Faso, Cameroon, Eswatini, Gabon, Ghana, Kenya, Malawi, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe. MAAP also reviewed data from 327 hospital and community pharmacies and 16 national-level AMC datasets. more

Download

View PDF

Add to my MEDBOX

Tuberculosis in the WHO African Region: 2023 progress update - September 2023

World Health Organisation (WHO) (2023) C_WHO

This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im ... portance of diagnosis and drug susceptibility testing, a focus onstrengthening laboratory networks and the regional laboratory and diagnostic objectives. A brief update of the state of the science and how this is funded across the African region is provided, before closing with challenges and opportunities,strategic directions and a brief discussion of funding concerns. Discussions around the drivers of the disease, and issues of the poverty, inequality and stigma that continue to plague those living with TB are fully recognized, but are outside the scope of this report. more

Download

View PDF

Add to my MEDBOX

Laboratory manual for yellow fever
recommended

World Health Organization WHO (2024) C_WHO

This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh ... ich operates within the WHO coordinated Global Yellow Fever Laboratory Network (GYFLaN) capable of providing confirmation of yellow fever infection reliably and timely. This second edition supersedes the first edition of the 2004 WHO manual for the monitoring of yellow fever virus infection. more

Add to my MEDBOX

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde ... d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Create your own MEDBOX
Login

Home
Contact
Data privacy
Legal notice
FAQ
About
Sitemap

A Project by

dev-medbox @ 2026

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Tanzania

Tuberculosis in the WHO African Region: 2023 progress update - September 2023

Laboratory manual for yellow fever recommended

Mpox Testing Strategy - November 2024

Laboratory manual for yellow fever
recommended